Results 101 to 110 of about 53,857 (331)
Anxiolytics: past, present, and future agents
, 2003 Although anxiety disorders were classified as neurotic disorders and not systematically studied before DSM-III, researchers and clinicians have been searching for effective, safe agents to treat anxiety symptoms and disorders for over a century.
Nemeroff, Charles B
core
Pharmacokinetics of Intravenous Melatonin in Preschool‐Aged Pediatric Surgical Patients
Pediatric Anesthesia, EarlyView.ABSTRACT Background Melatonin may have several beneficial clinical effects in the perioperative setting. In children, it has been studied for preoperative anxiety, postoperative pain, and emergence delirium. Melatonin's pharmacokinetic profile is well‐known in adults, but data in young children are sparse.
Anne Louise de Barros Garioud +4 more
wiley +1 more source
The pharmacology of anxiolytics
South African Family Practice, 2013 Given that anxiety disorders are common and chronic and often co-morbid with both medical and psychiatric conditions, effective and safe anxiolytic drugs are in great demand.
K. Outhoff
doaj +1 more source
A walk in the park—Identifying healthy greenspaces using scents
PLANTS, PEOPLE, PLANET, EarlyView.As urbanisation accelerates globally, access to nature is increasingly recognised as vital for public health and wellbeing. We captured and analysed plant‐emitted airborne ‘scent signatures’ across Oxford's urban greenspaces to assess their potential health relevance.
William T. Kay +6 more
wiley +1 more source
The Pharmacology of Anxiolytics
South African Family Practice, 2010 Given that anxiety disorders are common and chronic and often co-morbid with both medical and psychiatric conditions, effective and safe anxiolytic drugs are in great demand.
Kim Outhoff
doaj +1 more source
Dietary and botanical anxiolytics
Medical Science Monitor, 2012 Summary Drugs used to treat anxiety have many negative side effects including addiction, depression, suicide, seizures, sexual dysfunction, headaches and more.
Elham Alramadhan +5 more
semanticscholar +1 more source
ANXIOLYTICS IN DENTISTRY: AN UPDATED VIEW
, 2022 Anxiety is an emotional state that is most often temporary. However, it causes stress and discomfort, evolving into a disorder when it interferes with the individual's daily life. In dentistry, a considerable number of patients can manifest this behavior,
FERREIRA DOTTO, RONISE +5 more
core
Ashwagandha: Is It Safe? Part 2: A Preclinical Evidence Review
Phytotherapy Research, EarlyView.ABSTRACT The preclinical evidence for the safety of ashwagandha (Withania somnifera (L.) Dunal, AS) is reviewed, and its preparations (extracts) and constituents, from the general toxicity in animal models to in vitro and cell culture studies, which may elucidate mechanisms of action and explain clinical case reports.
Elizabeth M. Williamson, Thomas Brendler
wiley +1 more source
PRESCRIBING CHANGES IN ANXIOLYTICS AND ANTIDEPRESSANTS IN SLOVENIA
, 2011 Background: The ratio of anxiolytics to antidepressants is an indicator of the quality of treatment of depression and anxiety in primary care. The objective of the study was to investigate the prescription of anxiolytics and antidepressants among ...
Vidmar, Gaj +5 more
core
Phytotherapy Research, EarlyView.ABSTRACT Ashwagandha, an adaptogen, is an important herb of Ayurveda used as a Rasayana for its various health benefits. This prospective, multi‐center, observational clinical study evaluates the safety (clinical and laboratory) of a standardized Ashwagandha Root Extract (ARE) on long‐term administration over 12 months. Male and female adults (N = 191)
Jaising Salve +6 more
wiley +1 more source